dormakaba (DOKA) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
18 Sep, 2026Corporate governance and ownership structure
Proposal to simplify ownership structure, aligning economic interest at the holding company level and increasing free float to 72%.
Board size to be reduced from 10 to 8, with two members not standing for re-election; all others up for re-election.
Mankel family to contribute its stake in exchange for new shares, with a 15-year cap on increasing shareholding above 57%.
Chair of the Board remains independent with a casting vote; transaction subject to AGM approval.
Creation of CHF 2bn capital contribution reserves and enhanced capital markets profile.
Strategy and financial performance
Achieved CHF 235m in savings and reached a 16.1% adjusted EBITDA margin for the first time.
Streamlined portfolio with four divestments and exit from Russia; product consolidation underway.
Commercial transformation and improved demand planning on track for 2027/28.
Outlook for FY 2026/27: >3% organic net sales growth, >11% operating profit margin, 10.5–11.5% operating cash flow margin.
Proposed dividend of CHF 0.95 per share, up 3.3% year-over-year.
Board of directors and governance
Eight board members standing for re-election; no changes to committee composition.
Board skills include financial, industry, ESG, legal, digital, and M&A expertise.
Regular meetings cover strategy, performance, succession, ESG, and cybersecurity.
Ongoing evaluation and renewal process for board skills and succession planning.
Latest events from dormakaba
- Record margin and 3.0% organic growth achieved, with strong outlook and enhanced flexibility.DOKA
H2 2026 - Organic sales up 2.0%, margin at 15.6%, cost savings and acquisitions support outlook above 16%.DOKA
H1 2026 - Net sales up 4.1%, EBITDA margin 15.5%, net profit CHF 188m, dividend CHF 9.20 proposed.DOKA
H2 2025 - Digitalization, cost savings, and U.S. growth drive strong mid-term financial targets.DOKA
CMD 2024 - Organic sales up 4.7%, EBITDA margin at 14.7%, free cash flow up 15.9%, outlook targets ≥15% margin.DOKA
H2 2024 - Net profit nearly doubled on strong sales and margin gains, with upgraded full-year guidance.DOKA
H1 2025